ClinicalTrials.Veeva

Menu

MiDura-Study (Neuro-Patch in Duraplasty)

Aesculap logo

Aesculap

Status

Active, not recruiting

Conditions

Hydrocephalus
Spinal Surgery
Craniotomy
Meningioma
Duraplasty
Dural Fistula
Tethered Cord
Chiari Malformation
Tumor, Brain
Vascular Malformation

Study type

Observational

Funder types

Industry

Identifiers

NCT04189172
AAG-O-H-1630

Details and patient eligibility

About

The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer

Enrollment

328 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Age > 18 years
  • Duraplasty using Neuro-Patch® according to the Instructions for Use

Exclusion criteria

  • Use in infected regions
  • Use in open cerebrocranial traumata
  • Use in open spina bifida
  • Known hypersensitivity to implant materials
  • Pregnancy
  • Representation by a legal guardian or under involuntary commitment

Trial design

328 participants in 1 patient group

Neuro-Patch
Description:
Patients receiving Neuro-Patch® for duraplasty

Trial contacts and locations

4

Loading...

Central trial contact

Izabela Firkowska Boden, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems